Evommune is a clinical-stage biopharmaceutical company headquartered in Palo Alto, California, developing new treatments for immune-mediated chronic inflammatory diseases.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Evommune, Inc. →Already a subscriber? Sign in
Xcout Intel tracks Evommune, Inc. continuously — this profile deepens as new filings, funding, people and hiring data arrive.